High Growth Tech Stocks to Watch in September 2024 [Yahoo! Finance]
Sarepta Therapeutics, Inc. (SRPT)
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investorrelations.sarepta.com/events-and-presentations
Company Research
Source: Yahoo! Finance
Top 10 High Growth Tech Companies In The United States Sarepta Therapeutics ?????? TG Therapeutics ?????? Super Micro Computer ?????? Ardelyx ?????? G1 Therapeutics ?????? Invivyd ?????? Ascendis Pharma ?????? Travere Therapeutics ?????? Seagen ?????? ImmunoGen ?????? Let's uncover some gems from our specialized screener. Simply Wall St Growth Rating: ?????? Overview: Endava plc offers technology services across various sectors including consumer products, healthcare, mobility, and retail in North America, Europe, the United Kingdom, and internationally with a market cap of approximately $1.77 billion. Operations: Endava plc generates revenue primarily from computer services, amounting to £736.13 million. The company's market cap is approximately $1.77 billion. Endava, a tech firm with notable growth prospects, is forecasted to see earnings rise by 35.8% annually over the next three years. Despite a recent 57.2% dip in earnings, its r
Show less
Read more
Impact Snapshot
Event Time:
SRPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRPT alerts
High impacting Sarepta Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SRPT
News
- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $181.00 price target on the stock.MarketBeat
- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its price target raised by analysts at UBS Group AG from $173.00 to $188.00. They now have a "buy" rating on the stock.MarketBeat
- Sarepta Therapeutics Appoints Deirdre Connelly to its Board of DirectorsBusiness Wire
- High Growth Tech And 2 Other Promising Stocks For Your Portfolio [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Watch In September 2024 [Yahoo! Finance]Yahoo! Finance
SRPT
Earnings
- 8/7/24 - Beat
SRPT
Sec Filings
- 9/16/24 - Form 4
- 9/16/24 - Form 3
- 9/16/24 - Form 8-K
- SRPT's page on the SEC website